Viridian Therapeutics, Inc. · NASDAQ:VRDN
Viridian Therapeutics, Inc. shareholders
As of Jun 30, 2026, 207 institutions reported holding Viridian Therapeutics, Inc. Largest: Fidelity, BlackRock and Vanguard. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Viridian Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Fidelity | 16.6M | +1.23M | Aug 13, 2026 | |
| BlackRock | 8.55M | +720K | Aug 7, 2026 | |
| Vanguard | 8.1M | +1.6M | Aug 13, 2026 | |
| Bellevue Group AG | 6.73M | +5,765 | Aug 14, 2026 | |
| Paradigm Biocapital Advisors LP | 6.72M | +3.57M | Aug 14, 2026 | |
| Kynam Capital Management, LP | 6.45M | +4.11M | Aug 14, 2026 | |
| State Street | 6.12M | +1.45M | Aug 7, 2026 | |
| T. Rowe Price | 5.75M | +2.54M | Aug 14, 2026 | |
| Fairmount Funds Management LLC | 5.09M | +1.18M | Aug 14, 2026 | |
| Deep Track Capital, LP | 3.59M | +2.2M | Aug 14, 2026 |